Pre-Conference Focus Day: De-Mystifying Mergers & Acquisitions

Monday, August 29 | 2pm – 5pm 

Begin your In-House Impact: Life Sciences experience by tackling critical questions addressing the challenges associated with facing a Merger or Acquisition in the life sciences industry. This is your opportunity to hear from seasoned M&A lawyers from a variety of life sciences organizations – including Zymergen, Otsuka Pharmaceuticals, Center for Breakthrough Medicines & Bio-Techne.

Picture5 (1)

Where Are We Now?
What does the industry landscape look like in 2022? With issues such as a
challenging year for biotech stocks and the world learning to live with Covid-19-
what does this mean for the world of M&A?

Picture6 (1)

Different Perspectives
We have united a panel of expert General Counsel and senior lawyers from a wide
variety of companies- from Charles River Laboratories acquiring on average 5 biotechs a year, to the Center for Breakthrough Medicine looking at their options for acquisition.

Picture7 (2)

Successes & Lessons Learnt
What have been the learnings from all of these perspectives? We’ll hear our
panellists experience- from inception to closing- every stage of the deal process,
including practical steps, key considerations, and documentation.

Picture8

M&A Case Study Simulation Workshop
This workshop is designed to provide a deeper understanding of the overall
M&A transaction process. Participants will be given roles in as either acquiring or
acquiree, and a fictional case to play out over the course of the afternoon.

Your Pre-Conference Focus Day Contributors:

Amiel Gross

General Counsel

Center for Breakthrough Medicines

Brenda Furlow

Executive Vice President, General Counsel and Chief Compliance Officer

Bio-Techne

John Schiffhauer

Senior Vice President, Legal & Intellectual Property

Zymergen

Matthew Daniel

Corporate Senior Vice President, General Counsel, Corporate Secretary & Chief Compliance Officer

Charles River Laboratories